Harmony Garges MD
Consulting Associate in the Department of Pediatrics, Duke University
Join to View Full Profile
2100 Erwin RdDurham, NC 27705
Phone+1 919-684-8111
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Harmony Garges, MD is an infectious disease specialist in Durham, North Carolina. She is currently licensed to practice medicine in North Carolina. She is a Consulting Associate in the Department of Pediatrics at Duke University.
Education & Training
Duke University HospitalFellowship, Pediatric Infectious Diseases, 2002 - 2005- Duke University HospitalResidency, Pediatrics, 1998 - 2001
Duke University School of MedicineClass of 1998
Certifications & Licensure
NC State Medical License 2001 - 2025
American Board of Pathology Medical Microbiology
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Infectious Diseases
Publications & Presentations
PubMed
- 2 citationsWeight and Metabolic Changes With Long-Acting Cabotegravir and Rilpivirine or Bictegravir/Emtricitabine/Tenofovir Alafenamide.Darrell H S Tan, Andrea Antinori, Beng Eu, María José Galindo Puerto, Clifford Kinder
Journal of Acquired Immune Deficiency Syndromes. 2025-04-01 - Viremia Does Not Independently Predict Cardiovascular Disease in People With HIV: A RESPOND Cohort Study.Olof Elvstam, Lene Ryom, Bastian Neesgaard, Luba Tau, Huldrych F Günthard
Open Forum Infectious Diseases. 2025-02-01 - A simple tool to evaluate the effectiveness of HIV care for settings with gaps in data availability (ESTIHIV).Dorthe Raben, Marie L Jakobsen, Jamina Trajanovska, Justyna Kowalska, Anna Vassilenko
Plos One. 2025-01-01
Press Mentions
ViiV Healthcare Announces New Implementation Study Data Showing Zero Cases of HIV with Apretude, the Only Long-Acting Injectable Approved for HIV PrEPMarch 12th, 2025- ViiV Healthcare Expands on Real-World Data Supporting Use of Long-Acting Therapies in Diverse Patient Populations at HIV GlasgowNovember 7th, 2024
- Smart People: Dr Harmony P. GargesOctober 7th, 2020
- Join now to see all
